In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.

Chromatography Resins

Advances in the genomic sciences and biotechnology have led to an unprecedented need to rapidly isolate novel biotherapeutics for preclinical and clinical testing and then bring them to the market.

Sepragen Corporation specializes in providing advanced liquid chromatography devices to separate and purify biomolecules from the development stage to commercial production of biological drugs.
QuantaSep Family